Add to ORKGmicroRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation statu
Objectives: Lung adenocarcinoma is considered a unique disease for Asian female non-smokers. We inve...
We aimed to identify a panel of circulating plasma microRNAs that can predict EGFR mutation status a...
<div><p>Objectives</p><p>Lung adenocarcinoma is considered a unique disease for Asian female non-smo...
The findings of mutations and the development of targeted therapies have improved lung cancer manage...
Background: EGFR mutation is a strong predictor of efficacy of epidermal growth factor receptor tyro...
Lung cancer is a leading cause of cancer mortality worldwide. Several molecular pathways underlying ...
The EGFR gene was one of the first molecules to be selected for targeted gene therapy. EGFR-mutated ...
Background MicroRNAs (miRNAs) are short, non-coding RNAs that mediate post-transcriptional gene regu...
In recent years, in non-small cell lung cancer (NSCLC) targeted therapy, especially in patients with...
The introduction of EGFR-tyrosine kinase inhibitors (TKIs) has revolutionized the treatment and prog...
Lung cancer is a complex disease associated with gene mutations, particularly mutations of Kirsten R...
An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinom
Parallel Session 2 – Advanced Medical Research - no. S6Introduction & Project Objectives Lung cance...
Background: Lung cancer is a leading cause of cancer morbidity and mortality worldwide related to ad...
MicroRNAs (miRNAs) can act as oncosuppressors or oncogenes, induce chemoresistance or chemosensitivi...
Objectives: Lung adenocarcinoma is considered a unique disease for Asian female non-smokers. We inve...
We aimed to identify a panel of circulating plasma microRNAs that can predict EGFR mutation status a...
<div><p>Objectives</p><p>Lung adenocarcinoma is considered a unique disease for Asian female non-smo...
The findings of mutations and the development of targeted therapies have improved lung cancer manage...
Background: EGFR mutation is a strong predictor of efficacy of epidermal growth factor receptor tyro...
Lung cancer is a leading cause of cancer mortality worldwide. Several molecular pathways underlying ...
The EGFR gene was one of the first molecules to be selected for targeted gene therapy. EGFR-mutated ...
Background MicroRNAs (miRNAs) are short, non-coding RNAs that mediate post-transcriptional gene regu...
In recent years, in non-small cell lung cancer (NSCLC) targeted therapy, especially in patients with...
The introduction of EGFR-tyrosine kinase inhibitors (TKIs) has revolutionized the treatment and prog...
Lung cancer is a complex disease associated with gene mutations, particularly mutations of Kirsten R...
An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinom
Parallel Session 2 – Advanced Medical Research - no. S6Introduction & Project Objectives Lung cance...
Background: Lung cancer is a leading cause of cancer morbidity and mortality worldwide related to ad...
MicroRNAs (miRNAs) can act as oncosuppressors or oncogenes, induce chemoresistance or chemosensitivi...
Objectives: Lung adenocarcinoma is considered a unique disease for Asian female non-smokers. We inve...
We aimed to identify a panel of circulating plasma microRNAs that can predict EGFR mutation status a...
<div><p>Objectives</p><p>Lung adenocarcinoma is considered a unique disease for Asian female non-smo...